As of Jul 22
| +0.61 / +0.79%|
The 4 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 79.50, with a high estimate of 90.00 and a low estimate of 67.00. The median estimate represents a +1.90% increase from the last price of 78.02.
The current consensus among 5 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.